| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 51.77B | 60.29B | 48.90B | 38.41B | 27.40B | 20.63B |
| Gross Profit | 38.60B | 45.42B | 36.31B | 27.62B | 18.78B | 14.03B |
| EBITDA | 12.70B | 18.61B | 11.32B | 6.44B | 2.23B | 2.14B |
| Net Income | 9.47B | 13.29B | 8.00B | 4.18B | 1.27B | 1.08B |
Balance Sheet | ||||||
| Total Assets | 28.42B | 36.58B | 31.65B | 21.23B | 14.07B | 11.70B |
| Cash, Cash Equivalents and Short-Term Investments | 10.26B | 13.89B | 11.37B | 7.01B | 5.99B | 4.86B |
| Total Debt | 0.00 | 0.00 | 216.00M | 970.00M | 36.00M | 40.00M |
| Total Liabilities | 6.77B | 10.55B | 9.68B | 7.88B | 4.52B | 3.08B |
| Stockholders Equity | 21.64B | 26.03B | 21.98B | 13.35B | 9.55B | 8.62B |
Cash Flow | ||||||
| Free Cash Flow | 1.35B | 12.35B | 7.74B | 4.47B | 1.54B | -424.00M |
| Operating Cash Flow | 1.69B | 13.39B | 9.01B | 5.29B | 2.17B | -11.00M |
| Investing Cash Flow | -674.00M | -2.83B | -3.46B | -4.86B | -699.00M | -877.00M |
| Financing Cash Flow | -401.50M | -8.05B | -1.18B | 579.00M | -348.00M | -295.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
80 Outperform | ¥29.78B | 10.77 | ― | 4.36% | 7.11% | 20.03% | |
74 Outperform | ¥84.08B | 13.83 | ― | 2.32% | 8.80% | 16.40% | |
73 Outperform | ¥169.26B | 22.67 | ― | 2.55% | 17.67% | 24.39% | |
72 Outperform | ¥333.13B | 20.13 | ― | 0.22% | 23.27% | 67.12% | |
68 Neutral | ¥163.24B | 13.13 | 18.89% | 2.78% | 7.39% | 14.95% | |
65 Neutral | ¥30.39B | 20.84 | 10.34% | 4.82% | -2.76% | 36.33% | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% |